Breast Cancer: Targets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.6 | Q2 | 60.7% | 0.992 | Q2 | 83.7% |
| 2024 | 3.4 | Q2 | 64.1% | 0.944 | Q2 | 82.6% |
| 2023 | 3.3 | Q2 | 60.7% | 0.933 | Q2 | 83.8% |
| 2022 | 2.6 | Q3 | 35.7% | 0.834 | Q2 | 81.7% |
| 2021 | 5.1 | Q2 | 68.5% | 0.808 | Q2 | 81.4% |
| 2020 | — | — | 1.190 | Q2 | 88.8% | |
| 2019 | — | — | 1.410 | Q1 | 91.8% | |
| 2018 | — | — | 1.186 | Q2 | 87.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1179-1314
region
Pacific Region
coverage
2010-2026